Clinical efficacy and metabolomics study of Wendan Decoction in the treatment of phlegm-dampness obstructive sleep apnea-hypopnea syndrome with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Clinical efficacy and metabolomics study of Wendan Decoction in the treatment of phlegm-dampness obstructive sleep apnea-hypopnea syndrome with type 2 diabetes mellitus

Published:2023-12 Issue: Volume:317 Page:116775
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Zhou Sifeng^ORCID,Xu Haishu,Zhu Jieyun,Fan Xinsheng,Zhang Jinming

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference44 articles.

1. Obesity connected metabolic changes in type 2 diabetic patients treated with metformin;Aleidi;Front. Pharmacol.,2021

2. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis;Benjafield;Lancet Respir. Med.,2019

3. Current therapies and targets for type 2 diabetes mellitus;Chellappan;Panminerva Med.,2018

4. Discovery of molecular mechanism of a clinical herbal formula upregulating serum HDL-c levels in treatment of metabolic syndrome by in vivo and computational studies;Chen;Bioorg. Med. Chem. Lett.,2018

5. Effects of free fatty acids on hepatic glycogenolysis and gluconeogenesis in conscious dogs;Chu;Am J Physiol-Endoc M,2002

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined analysis of gut microbiota and metabolomics in high-fat model mice fed with Chlorella pyrenoidosa peptides;Journal of Functional Foods;2024-10

2. Ji-Ni-De-Xie ameliorates type 2 diabetes mellitus by modulating the bile acids metabolism and FXR/FGF15 signaling pathway;Frontiers in Pharmacology;2024-05-21

3. Review on analytical technologies and applications in metabolomics;BIOCELL;2024